Kimberly Murphy - 12 Dec 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role: Director
Signature: /s/ Steven A. Bourne, attorney-in-fact
Issuer symbol: CRXT
Transactions as of: 12 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 14 Dec 2021, 18:00:11 UTC
Next filing: 20 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRXT	Common Stock	Award	$0	+3,844		$0	3,844	12 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRXT	Stock Option (Right to Buy)	Award	$0	+9,610		$0	9,610	12 Dec 2021	Common Stock	9,610	$4.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
F2	These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.